DF
NEO icon

Dunhill Financial’s NeoGenomics NEO Stock Holding History

Dunhill Financial’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$13 Sell
1
-1
-50% -$11 ﹤0.01% 1811
2025
Q4 		$21 Buy
+2
New +$22 ﹤0.01% 1898

Other funds holding NEO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
GF
Greenhouse Funds Baltimore, Maryland $2.23B AUM 12.38% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Dunhill Financial's NEO Position: Q1 2026 in Review

Dunhill Financial reduced its NeoGenomics (NEO) stake by 50% in Q1 2026, selling an estimated $11 and leaving 1 share worth $13. The position accounts for ﹤0.01% of the portfolio, ranked #1811.

Dunhill Financial first reported a position in NEO in Q4 2025 and has held it in 2 quarters since. The position peaked at $21 in Q4 2025. 253 funds tracked by Wall St. Rank hold NEO as of Q1 2026.

  • Dunhill Financial held 1 share of NeoGenomics worth $13 as of Q1 2026.
  • Dunhill Financial sold 1 NeoGenomics share in Q1 2026, an estimated $11.
  • NeoGenomics made up ﹤0.01% of Dunhill Financial's portfolio in Q1 2026, its #1811 holding.
  • Dunhill Financial first reported a position in NeoGenomics in Q4 2025 and has held it in 2 quarters since.
  • Dunhill Financial's NeoGenomics position peaked at $21 in Q4 2025.
  • 253 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2026.

Based on Dunhill Financial's 13F filing for Q1 2026, filed 6 May 2026.